Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Hoffmann-La Roche
Catholic University of the Sacred Heart
Asan Medical Center
Johannes Gutenberg University Mainz
Tarveda Therapeutics
AIO-Studien-gGmbH
Yale University
Vanderbilt-Ingram Cancer Center
Novartis
University of Turin, Italy